-
1
-
-
0037029424
-
Multiple sclerosis
-
Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221-31.
-
(2002)
Lancet
, vol.359
, pp. 1221-1231
-
-
Compston, A.1
Coles, A.2
-
3
-
-
0036720739
-
A randomized multicentre comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
-
Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K et al. A randomized multicentre comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100: 1525-31.
-
(2002)
Blood
, vol.100
, pp. 1525-1531
-
-
Couban, S.1
Simpson, D.R.2
Barnett, M.J.3
Bredeson, C.4
Hubesch, L.5
Howson-Jan, K.6
-
4
-
-
0031907910
-
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: Report on the first three patients
-
Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 537-41.
-
(1998)
Bone Marrow Transplant
, vol.21
, pp. 537-541
-
-
Burt, R.K.1
Traynor, A.E.2
Cohen, B.3
Karlin, K.H.4
Davis, F.A.5
Stefoski, D.6
-
5
-
-
0034093120
-
Autologous stem cell transplantation in progressive multiple sclerosis - An interim analysis of efficacy
-
Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al. Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis of efficacy. J Clin Immunol 2000; 20: 24-30.
-
(2000)
J Clin Immunol
, vol.20
, pp. 24-30
-
-
Fassas, A.1
Anagnostopoulos, A.2
Kazis, A.3
Kapinas, K.4
Sakellari, I.5
Kimiskidis, V.6
-
6
-
-
0034576841
-
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning, report of toxicity and immunological monitoring
-
Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning, report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 6: 563-75.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 563-575
-
-
Openshaw, H.1
Lund, B.T.2
Kashyap, A.3
Atkinson, R.4
Sniecinski, I.5
Weiner, L.P.6
-
7
-
-
0034060611
-
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis
-
Kozak T, Havrdova E, Pit'ha J, Gregora E, Pytlik R, Maaloufova J et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000; 25: 525-31.
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 525-531
-
-
Kozak, T.1
Havrdova, E.2
Pit'ha, J.3
Gregora, E.4
Pytlik, R.5
Maaloufova, J.6
-
8
-
-
18544374335
-
Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study
-
Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088-97.
-
(2002)
J Neurol
, vol.249
, pp. 1088-1097
-
-
Fassas, A.1
Passweg, J.R.2
Anagnostopoulos, A.3
Kazis, A.4
Kozak, T.5
Havrdova, E.6
-
9
-
-
0036655742
-
Prospects for stem cell transplantation in multiple sclerosis
-
Kilpatrick TJ, Butzkueven H, Grigg A. Prospects for stem cell transplantation in multiple sclerosis. J Clin Neurosci 2002; 9: 361-7.
-
(2002)
J Clin Neurosci
, vol.9
, pp. 361-367
-
-
Kilpatrick, T.J.1
Butzkueven, H.2
Grigg, A.3
-
10
-
-
0028264426
-
Cladribine in treatment of chronic progressive multiple sclerosis
-
Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 1994; 344: 9-13.
-
(1994)
Lancet
, vol.344
, pp. 9-13
-
-
Sipe, J.C.1
Romine, J.S.2
Koziol, J.A.3
McMillan, R.4
Zyroff, J.5
Beutler, E.6
-
11
-
-
0034646216
-
Cladribine and progressive MS. Clinical and MRI outcomes of a multicenter controlled trial
-
Cladribine MRI Study Group
-
Rice GP, Filippi M, Comi G. Cladribine and progressive MS. Clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology 2000; 54: 1145-55.
-
(2000)
Neurology
, vol.54
, pp. 1145-1155
-
-
Rice, G.P.1
Filippi, M.2
Comi, G.3
-
12
-
-
0029983154
-
The treatment of chronic progressive multiple sclerosis with cladribine
-
Beutler E, Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J. The treatment of chronic progressive multiple sclerosis with cladribine. Proc Natl Acad Sci USA 1996; 93: 1716-20.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 1716-1720
-
-
Beutler, E.1
Sipe, J.C.2
Romine, J.S.3
Koziol, J.A.4
McMillan, R.5
Zyroff, J.6
-
13
-
-
0020686503
-
New diagnostic criteria for multiple sclerosis. Guidelines for research protocols
-
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
-
(1983)
Ann Neurol
, vol.13
, pp. 227-231
-
-
Poser, C.M.1
Paty, D.W.2
Scheinberg, L.3
McDonald, W.I.4
Davis, F.A.5
Ebers, G.C.6
-
14
-
-
0029913882
-
Defining the course of multiple sclerosis: Results of an international survey
-
Lublin FD, Reìngold SC. Defining the course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
-
(1996)
Neurology
, vol.46
, pp. 907-911
-
-
Lublin, F.D.1
Reìngold, S.C.2
-
15
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
-
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
16
-
-
0028210972
-
Marrow suppression produced by repeated doses of cladribine
-
Beutler E, Koziol JA, McMillan R, Sipe JC, Romine JS, Carrera CJ. Marrow suppression produced by repeated doses of cladribine. Acta Haematol 1994; 91: 10-5.
-
(1994)
Acta Haematol
, vol.91
, pp. 10-15
-
-
Beutler, E.1
Koziol, J.A.2
McMillan, R.3
Sipe, J.C.4
Romine, J.S.5
Carrera, C.J.6
-
17
-
-
0034643935
-
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor
-
Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 13: 2147-50.
-
(2000)
Neurology
, vol.13
, pp. 2147-2150
-
-
Openshaw, H.1
Stuve, O.2
Antel, J.P.3
Nash, R.4
Lund, B.T.5
Weiner, L.P.6
-
18
-
-
0037153729
-
Mitoxantrone in progressive multiple sclerosis: A placebo-controlled, double-blind, randomised, multicentre trial
-
Hartung HP, Gonsette R, Konig N, Kwiecinski H, Guseo A, Morrissey SP et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 2002; 360: 2018-25.
-
(2002)
Lancet
, vol.360
, pp. 2018-2025
-
-
Hartung, H.P.1
Gonsette, R.2
Konig, N.3
Kwiecinski, H.4
Guseo, A.5
Morrissey, S.P.6
|